The article discusses the fascination with novel therapies like MDMA-assisted treatment for PTSD and the importance of also recognizing and advocating for existing effective treatments. It highlights the challenges and delays involved in developing new pharmacological treatments and emphasizes the need to balance innovation with practical solutions available today. The article stresses the significance of addressing the immediate needs of PTSD sufferers with clinically validated treatments and advocates for broader access to existing treatments. It concludes by emphasizing the moral imperative of providing real relief to those suffering from PTSD while still paving the way for future advancements in mental health care.
Source link
Why Wait? The Urgency of Accessible PTSD Treatments Now
